Top

RECOVERY: In Vitro Screening of Combinations of Chemotherapy Drugs

Active

RECOVERY-HHSN261200522001C-Modification11Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

The contract awarded to SRI International on September 20, 2010, involves a cost reimbursement agreement valued at $3.1 million for in vitro screening of chemotherapy drug combinations. The project leverages advanced molecular biology techniques—including genomics, iRNA, and proteomics—along with computational and statistical modeling, such as response surface mapping for synergy, and robotics to enhance drug screening processes. The contract was competitively procured, and its nature required a cost reimbursement model due to the complexity and unpredictability of costs, making a fixed-price approach unsuitable. This undertaking focuses on applying state-of-the-art scientific methods to optimize chemotherapy drug combinations, aiming to improve therapeutic outcomes. The contract includes stringent measures to ensure that all costs are allowable, allocable, fair, and reasonable. The solicitation falls under NAICS code 541711, relating to research and development in biotechnology, with oversight by Contracting Officer Stanley A. Knight. The overall scope emphasizes the integration of multidisciplinary techniques in a research-focused environment to accelerate drug discovery efforts.

General Info

SRI International awarded $3.1M for advanced molecular screening of chemotherapy drug combinations.

Agency

N/A

NAICS

541711 - Research and Development in Biotechnology

Place of Performance

Not specified

Set-Aside

NONE

Documents

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PostedSep 29

special-notice

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

AgencyN/A

Contacts1 person available

OfficeN/A

Organization / Agency

N/A

Office AddressN/A

Contacts

Stanley A. KnightContracting Officer

contact@example.gov

+1 (555) 000-0000

Full Description

NOTE: THIS IS NOT A SOLICITATION. THIS IS AN ARRA AWARD SPECIAL NOTICE. Award Notice (ARRA Award) Solicitation Number: HHSN261200522001C Procurement Type: Cost Reimbursement DUNS Number: 009232752 Title: RECOVERY: In Vitro Screening of Combinations of Chemotherapy Drugs Contract/Modification Award Date: 09/20/2010 Award Dollar Amount: $3,100,000 Contractor Awarded Name: SRI International Description: The services will support application of techniques in molecular biology, (genomics, iRNA, proteomics, etc.) computational and statistical modeling (response surface mapping for synergy, etc.) and robotics into an applied drug screening effort. This action was a competitive procurement, utilizing a cost reimbursement type contract mechanism. The nature of the project requirements described in the Statement of Work (SOW) do not contain precise specifications to warrant a fixed-price mechanism. Further, difficulty in estimating costs with accuracy does not lend this requirement to a fixed-price mechanism. Therefore, a cost reimbursement type contract is appropriate for this acquisition. Sufficient safeguards will be included in the contract to ensure that costs are allowable, allocable, fair, and reasonable.